• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Cancer imaging technology can help reveal life-threatening pregnancy disorder

Bioengineer by Bioengineer
March 12, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Photoacoustic imaging can help detect preeclampsia, which accounts for 14 percent of global maternal deaths annually

An imaging technique used to detect some forms of cancer can also help detect preeclampsia in pregnancy before it becomes a life-threatening condition, a new Tulane study says.

Preelcampsia is a hypertensive disorder that accounts for 14 percent of global maternal deaths annually and affects 5 to 8 percent of all pregnancies. Symptoms may include high blood pressure and protein in the urine and typically occurs after the 20th week of pregnancy.

The study, published in the open-access journal Scientific Reports was led by Carolyn Bayer, an assistant professor of biomedical engineering, along with a team of graduate students and researchers with the Tulane School of Medicine and Tulane School of Public Health and Tropical Medicine.

The study was conducted on pregnant rats using spectral photoacoustic imaging, a noninvasive procedure that can detect placental ischemia – a sign of possible preeclampsia – prior to the onset of symptoms, such as high blood pressure, severe headaches and dizziness.

Photoacoustic images were acquired of the placenta of normal pregnant rats and rats with preeclampsia on various days of gestation. Two days after inducing preeclampsia, the average placental oxygenation decreased 12 percent in comparison to normal pregnant rats.

“Spectral photoacoustic imaging is a powerful preclinical tool that has many promising applications in the understanding and treatment of pregnancy-related diseases,” Bayer said.

“It provides new imaging techniques to look at the progression of the disease through gestation, which might be a better way to understand which patients need interventions to treat the preeclampsia.”

Because it is a noninvasive procedure, it poses little to no risk to the fetus, compared to cordocentesis, a fetal blood sampling that is much more dangerous.

Photoacoustic imaging may be used to detect breast, ovarian and other types of cancers.

###

Other researchers in the study include Dylan Lawrence and Megan Escott, both graduate students in Bayer’s lab; Leann Myers, a biostatistics professor in the School of Public Health and Tropical Medicine; and Suttira Intapad and Sarah Lindsey, assistant professors of pharmacology at Tulane Medical School.

The study was funded in part by the Carol Lavin Bernick Faculty Grant, the Louisiana Board of Regents Graduate Fellowship and the National Institutes of Health.

Media Contact
Barri Bronston
[email protected]

Related Journal Article

https://news.tulane.edu/pr/pregnancy-disorder-subject-new-tulane-study
http://dx.doi.org/10.1038/s41598-018-37310-2

Tags: Biomedical/Environmental/Chemical EngineeringBreast CancerTechnology/Engineering/Computer Science
Share13Tweet8Share2ShareShareShare2

Related Posts

blank

Serum Markers Predict Atrial Fibrillation in Diabetes

August 2, 2025
blank

Amyloid Fibrils Connect CHCHD10, CHCHD2 to Neurodegeneration

August 2, 2025

Mapping the Human Hippocampus: Single-Nucleus to Spatial Transcriptomics

August 2, 2025

Boosting ADMET Predictions for Key CYP450s

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    45 shares
    Share 18 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Serum Markers Predict Atrial Fibrillation in Diabetes

Intrapleural Anti-VEGF Boosts Nab-Paclitaxel Efficacy

Amyloid Fibrils Connect CHCHD10, CHCHD2 to Neurodegeneration

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.